TGFB1 and breast carcinoma: Indeed, we found that emodin could effectively reduce TGF-β1-induced expression of CSC markers in multiple breast cancer cell lines and diminish their ability to form mammospheres in vitro (mammosphere formation assays) and to generate tumors in vivo (limited dilution assays) (Figure 3).